AbbVie stock (ABBV) has a tokenised version, ABBVx, a blockchain based asset that represents AbbVie shares. Each ABBVx token is backed 1:1 by real AbbVie shares held in regulated custody. AbbVie is a biopharmaceutical company that was spun off from Abbott in 2013. Its portfolio covers immunology, oncology, neuroscience and aesthetics, with products such as Skyrizi, Rinvoq and Botox, the last added through its 2020 acquisition of Allergan. AbbVie is headquartered in North Chicago, Illinois. Holding ABBVx gives you indirect exposure to AbbVie shares, but it is not the same as owning the underlying shares and does not come with shareholder rights.